Our data from alpha-synucleinopathy mouse models are consistent with a proteome survey of midbrain from sporadic PD patients, which reported significantly elevated levels for complexin-1 and a trend towards elevated levels of 14-3-3 epsilon [26]. Here, CPLX1 is linked to synucleinopathy.